Mayo Clinic and Thermo Fisher spin out Precure to target pharma and AI firms with multiomic database

Mayo Clinic and Thermo Fisher have spun out Precure, a company that will offer a multiomic database to pharmaceutical and AI firms.

Summaries like this, in your inbox every morning.

Get the latest AI in Healthcare news every morning

For example, today's edition would include:

Community oncologists turn to AI, but not all use predictive modelsTop Companies AI · 3h ago
Tokyo Science Univ. robot lab targets iPS regenerative medicineTop Companies AI · 3h ago
AI device nodoca reads throat images to spot influenza signsNikkei AI Stocks · 3h ago

AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.

Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →

Ask AI anything about this article. Q&As are published on this page for other readers too.

Simply Wall St's most-followed KLA narrative sets fair value at $232.43 versus a $176.99 close, with the stock…

Nvidia founder and CEO Jensen Huang told CBS News that AI development should move 'as fast as we can irrespect…

Visa joined Mastercard and Ant International to design a shared Know Your Agent framework, aimed at standardis…

Broadcom projected roughly $58 billion in AI semiconductor revenue for fiscal 2026, about $115 billion in fisc…

Aehr Test Systems reported FY2026 revenue of $50.0 million, down 15.2% from the prior year, and a net loss of…

Citi said it expects a hawkish Fed to slow the non-AI economy

Ask the AI about this article